Functional in vivo studies tend to indicate protective effects of the AT2 receptor against stroke, Alzheimer disease, and cognitive impairment [26, 33, 41–45]. The gene discussed is AGTR2; the disease is early-onset autosomal dominant Alzheimer disease.